American Research & Management Company’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.52M Buy
30,520
+1,594
+6% +$153K 0.7% 42
2022
Q2
$2.75M Buy
28,926
+1,220
+4% +$126K 0.71% 42
2022
Q1
$3.26M Buy
27,706
+74
+0.3% +$8.3K 0.72% 43
2021
Q4
$3.58M Sell
27,632
-10
-0% -$1.17K 0.77% 41
2021
Q3
$3.13M Sell
27,642
-65
-0.2% -$7.42K 0.72% 41
2021
Q2
$2.87M Buy
27,707
+1,145
+4% +$108K 0.65% 46
2021
Q1
$2.22M Buy
26,562
+117
+0.4% +$9.89K 0.54% 48
2020
Q4
$2.41M Buy
26,445
+363
+1% +$30.1K 0.63% 45
2020
Q3
$2.08M Hold
26,082
0.61% 44
2020
Q2
$1.8M Buy
+26,082
New +$1.85M 0.55% 49
2018
Q3
Sell
-23,580
Closed -$1.14M 344
2018
Q2
$1.14M Buy
+23,580
New +$1.1M 0.4% 56
2017
Q4
Sell
-22,230
Closed -$810K 362
2017
Q3
$810K Buy
22,230
+300
+1% +$11.4K 0.26% 71
2017
Q2
$864K Buy
21,930
+900
+4% +$32.9K 0.28% 69
2017
Q1
$659K Buy
21,030
+1,305
+7% +$40.9K 0.23% 67
2016
Q4
$616K Buy
+19,725
New +$639K 0.21% 74
2016
Q3
Sell
-3,900
Closed -$147K 98
2016
Q2
$130K Buy
+3,900
New +$133K 0.05% 114

Other funds holding EW

American Research & Management Company's EW Position: Q3 2022 in Review

American Research & Management Company increased its Edwards Lifesciences (EW) stake by 5.5% in Q3 2022, buying an estimated $153K and bringing the position to 30,520 shares worth $2.52M. The position accounts for 0.7% of the portfolio, ranked #42.

American Research & Management Company first reported a position in EW in Q2 2016 and has held it in 16 quarters since. The position peaked at $3.58M in Q4 2021. 1,247 funds tracked by Wall St. Rank hold EW as of Q3 2022.

  • American Research & Management Company held 30,520 shares of Edwards Lifesciences worth $2.52M as of Q3 2022.
  • American Research & Management Company bought 1,594 Edwards Lifesciences shares in Q3 2022, an estimated $153K.
  • Edwards Lifesciences made up 0.7% of American Research & Management Company's portfolio in Q3 2022, its #42 holding.
  • American Research & Management Company first reported a position in Edwards Lifesciences in Q2 2016 and has held it in 16 quarters since.
  • American Research & Management Company's Edwards Lifesciences position peaked at $3.58M in Q4 2021.
  • 1,247 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.